CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) of $1.20 billion for the 12-month period ending 2014-12-27, per its 10-K filed 2015-02-17.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount · last filed 2015-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2014-12-27 was $200.00M, a 80.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2014-09-27 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2013-12-28 was $1.00B.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2013-09-28 was $100.00M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for fiscal 2014 was $1.20B, a 380.00% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for fiscal 2013 was $250.00M.
| Period end | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 0 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 12 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2014-12-27 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $200.00M derived: sum of 2 quarters · filed 2015-02-17 | $1.20B 10-K · filed 2015-02-17 | ||||
| 2014-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.00B 10-Q · filed 2014-10-30 | |||||
| 2014-06-28 | $1.00B 10-Q · filed 2014-08-07 | ||||||
| 2013-12-28 | $1.00B 10-K · filed 2014-02-25 | $1.10B derived: sum of 2 quarters · filed 2014-02-25 | $250.00M 10-K · filed 2014-02-25 | $850.00M 10-Q · filed 2013-07-31 | |||
| 2013-09-28 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $850.00M 10-Q · filed 2013-10-30 | |||||
| 2013-06-29 | $750.00M 10-Q · filed 2013-10-30 | ||||||
| 2011-06-25 | $750.00M 10-Q · filed 2011-08-03 | ||||||
| 2010-10-31 | $750.00M 10-Q · filed 2011-11-02 | ||||||
| 2010-10-20 | $750.00M 10-K · filed 2014-02-25 | ||||||
| 2010-08-26 | $300.00M 10-K · filed 2014-02-25 | ||||||
| 2010-07-31 | $500.00M 10-Q · filed 2014-10-30 | ||||||
| 2010-07-29 | $500.00M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |